T2 Biosystems, Inc.

T2 Biosystems Announces Issuance of Key Patent Providing Broad Intellectual Property Protection for Direct Detection Diagnostic Methods

T2 Biosystems Announces Issuance of Key Patent Providing Broad Intellectual Property Protection for Direct Detection Diagnostic Methods

February 2, 2012

Lexington, MA – T2 Biosystems, a company developing direct detection products enabling superior diagnostics, today announced the issuance of patent number 8,102,176 by the United States Patent and Trademark Office entitled

Joule Unlimited, Inc.

JOULE ELECTS ANATOLY CHUBAIS TO BOARD OF DIRECTORS

JOULE ELECTS ANATOLY CHUBAIS TO BOARD OF DIRECTORS

February 2, 2012

THE RUSSIA FORUM – Moscow, Russia – February 2, 2012 – Joule today announced the election of Anatoly Chubais to its board of directors, adding the expertise and insight of a prominent figure in international business, economics and government. The news was released in conjunction with Joule’s participation at the Russia Forum, an annual meeting of high-profile international economists and business leaders.

Avedro, Inc.

Avedro Announces Canadian Approval for Lasik Xtra™

Avedro Announces Canadian Approval for Lasik Xtra™

January 31, 2012

WALTHAM, Mass.--(BUSINESS WIRE)--Avedro, Inc. announced today that the Company’s proprietary Lasik Xtra procedure has received Canadian Approval. Lasik Xtra is a two minute procedure used in conjunction with standard Lasik to restore biomechanical integrity and strength to the cornea after a standard Lasik procedure. The procedure combines riboflavin ophthalmic solution with Avedro’s KXL™ System (UVA irradiation) to achieve accelerated corneal cross-linking during a Lasik procedure.

Affinnova, Inc.

Affinnova Launches Concept Studio for Collaborative Innovation

Affinnova Launches Concept Studio for Collaborative Innovation

January 26, 2012

WALTHAM, Mass., Jan 26, 2012 -- Today - at the Online Research Methods conference in London - Affinnova, Inc., the global leader in marketing innovation software and services, introduced Affinnova Concept Studio, a web-based application that accelerates concept collaboration and development for new products, designs and ad campaigns.

BARDA biothreat contract could bring $40M to Tetraphase

BARDA biothreat contract could bring $40M to Tetraphase

January 25, 2012

Synthetic chemistry company Tetraphase Pharmaceuticals Inc. of Watertown could get $40 million from a federal contract to develop an antibiotic to potentially treat illnesses resulting from biological threats such as anthrax, tularemia or pestis, the company told Mass High Tech in an interview.

Click on Mass High Tech logo to view full article

 

 

Oasys Water, Inc.

Oasys Water Appoints Bob Muscat as New Chief Executive Officer to Drive Commercialization

Oasys Water Appoints Bob Muscat as New Chief Executive Officer to Drive Commercialization

January 23, 2012

BOSTON -- Oasys Water, a leader in forward osmosis technology for desalination, brine recovery and water reuse, today announced the appointment of Bob Muscat as Chief Executive Officer. The appointment marks the beginning of the company’s commercialization phase.

Selventa

Selventa Granted Patent for Discovery of Biomarker Profiles

Selventa Granted Patent for Discovery of Biomarker Profiles

January 23, 2012

CAMBRIDGE, Mass., Jan 23, 2012 (BUSINESS WIRE) -- Selventa(TM), a biomarker discovery company that enables personalized healthcare through stratification of patients based on disease-driving mechanisms, today announced that the U.S. Patent & Trademark Office has issued the Company U.S.

Joule Unlimited, Inc.

Joule Prepares for Global Deployment with Appointment of Proven Industry Experts to Lead Commercial Operations

Joule Prepares for Global Deployment with Appointment of Proven Industry Experts to Lead Commercial Operations

January 23, 2012

Bedford, Mass. – January 23, 2012 – Joule today announced the appointment of two key executives to manage the company's roll-out of renewable fuel production facilities worldwide. Peter Erich has joined as Executive Vice President, General Manager Commercial Operations, and will lead the team responsible for site development and technology deployment. Paul Snaith has been appointed to build and manage the related partnerships as Head of Business Development & Strategy.

Tetraphase Pharmaceuticals, Inc.

Tetraphase Appoints L. Patrick Gage, Ph.D., as Chairman of the Board

Tetraphase Appoints L. Patrick Gage, Ph.D., as Chairman of the Board

January 18, 2012

WATERTOWN, Mass.--(BUSINESS WIRE)--Tetraphase Pharmaceuticals, Inc., a clinical-stage life science company developing a portfolio of potent new antibiotics, today announced that L. Patrick “Pat” Gage, Ph.D., biopharmaceutical industry pioneer, has been appointed as the company’s Chairman of the Board. In this role, Dr.

Affinnova, Inc.

Affinnova Helps Sbarro Serve up an Optimized Pricing Strategy

Affinnova Helps Sbarro Serve up an Optimized Pricing Strategy

January 18, 2012

WALTHAM, Mass.--(BUSINESS WIRE)--Facing rising food costs and softening industry traffic, Sbarro, the world’s leading Italian quick service restaurant, turned to Affinnova, Inc., the global leader in marketing innovation software and services, to help strategically optimize its menu pricing. Understanding that traditional point-of-sale tracking data would not provide enough guidance, Sbarro used Affinnova’s technology to perform a holistic review of its pricing strategy.